top of page

CHO-K1/Mouse FPR2-ALX Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0091B

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


Formylpeptide receptor 2 (FPR2) is a G protein-coupled receptor with broad ligand selectivity, belonging to the same formyl peptide receptor family as FPR1. It is primarily expressed on myeloid immune cells such as neutrophils and monocytes/macrophages, as well as in epithelial cells, astrocytes, and various tissues including the lung, liver, and heart. FPR2 performs complex and diverse functions: it can not only initiate antimicrobial inflammatory responses by recognizing bacterial-derived formylated peptides but also responds to various endogenous ligands (such as Annexin A1, lipoxin A4, and amyloid-β), thereby playing a key role in regulating inflammation resolution (exhibiting both pro- and anti-inflammatory effects), promoting tissue repair, and clearing cellular debris. Dysregulation of its signaling pathways is closely associated with numerous diseases, including chronic inflammation, atherosclerosis, Alzheimer's disease, and cancer.

 

Screeningbio’s CHO-K1/Mouse FPR2/ALX cell line overexpress FPR2 and is designed to detect inhibition in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Mouse

HGNC Symbol

FPR2/ALX

Accession Number

NM_008039

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data


CHO-K1/Mouse FPR2-ALX Agonist Assay. CHO-K1/Mouse FPR2-ALX cells were stimulated with 2.5 μM Forskolin and treated with control agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Mouse FPR2-ALX Agonist Assay. CHO-K1/Mouse FPR2-ALX cells were stimulated with 2.5 μM Forskolin and treated with control agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


Formylpeptide receptor 2 (FPR2) is a G protein-coupled receptor with broad ligand selectivity, belonging to the same formyl peptide receptor family as FPR1. It is primarily expressed on myeloid immune cells such as neutrophils and monocytes/macrophages, as well as in epithelial cells, astrocytes, and various tissues including the lung, liver, and heart.


FPR2 performs complex and diverse functions: it can not only initiate antimicrobial inflammatory responses by recognizing bacterial-derived formylated peptides but also responds to various endogenous ligands (such as Annexin A1, lipoxin A4, and amyloid-β), thereby playing a key role in regulating inflammation resolution (exhibiting both pro- and anti-inflammatory effects), promoting tissue repair, and clearing cellular debris.


Dysregulation of its signaling pathways is closely associated with numerous diseases, including chronic inflammation, atherosclerosis, Alzheimer's disease, and cancer.



Product Documentation



bottom of page